Welcome
to the Standard
Care vs. Corticosteroid for Retinal Vein Occlusion
(SCORE) Study home page.
The SCORE Study was a multi-center, randomized Phase III trial designed to assess the efficacy and safety of
standard care versus triamcinolone acetonide injection(s) for the treatment of macular edema associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). The study was completed in February 2009. For more information about the SCORE Study, email the SCORE Coordinating Center at score@emmes.com or call 301-251-1161.
The SCORE Study was sponsored
by the National Eye Institute, National Institutes of Health, Department
of Health and Human Services in Bethesda, Maryland.
